Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Non-metastatic cells 4 pseudogene (NME4P) is a pseudogene present in the human genome that shares sequence similarity with the protein-coding NME4 gene, but does not code for a functional protein[5]. Pseudogenes arise when mutations—such as insertions, deletions, or early stop codons—render a gene nonfunctional, preventing translation into protein[2][6][8]. Initially considered "junk DNA," some pseudogenes can be transcribed into RNA and may exert regulatory roles by acting as decoys for microRNAs or other regulatory molecules, but most do not play an active biological role[2][7][6][1]. There is no evidence that NME4 pseudogene encodes a receptor, enzyme, or other recognized therapeutic target, nor is it directly implicated in human disease as a protein product[5][2]. Summary: This name refers to a pseudogene, not a functional target. Pseudogenes are non-coding, often nonfunctional gene-like sequences, though some may have regulatory RNA roles. This entity is not a drug target, does not interact with drugs, and is not used as a biomarker or associated with therapeutic safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-metastatic cells 4 pseudogene (NME4P).